Ferroptosis induction is a particularly attractive therapeutic strategy for ccRCC since the metabolic reprogramming associated with pVHL loss that increases lipid storage and impairs fatty acid oxidation renders ccRCC cells exquisitely sensitive to ferroptosis induction [38, 69]. Here, VHL is linked to nonpapillary renal cell carcinoma.